SCHEMBL5216832

SCHEMBL5216832

CC(N)c1cccc(-c2ccccn2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSL P07711 1/20 0.48
CTSK P43235 1/20 0.48
CYP2A6 P11509 1/20 0.43
HTR1A P08908 1/20 0.42
HTR7 P34969 1/20 0.42
KDM4E B2RXH2 2/20 0.42
LMNA P02545 2/20 0.42
CCR1 P32246 2/20 0.42
CCR5 P51681 2/20 0.42
CCR8 P51685 2/20 0.42
CYP1A2 P05177 1/20 0.42
POLB P06746 1/20 0.42
METAP1 P53582 1/20 0.42
BLM P54132 1/20 0.42
HIF1A Q16665 1/20 0.42
DOHH Q9BU89 1/20 0.42
P4HTM Q9NXG6 1/20 0.42
TLR4 O00206 1/20 0.41
TLR2 O60603 1/20 0.41
TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5249260 1.00 CTSL (0.48) CTSLCTSKCYP2A6HTR1AHTR7
SCHEMBL29793885 1.00 CTSL (0.48) CTSLCTSKCYP2A6HTR1AHTR7
SCHEMBL9261215 0.86 CTSK (0.50) CTSLCTSKCYP2A6HTR1AHTR7
SCHEMBL20023732 0.81 CYP1A2 (0.47) CYP2A6KDM4ELMNACCR1CCR5
SCHEMBL28405109 0.81 CLK4 (0.49) CYP2A6IRAK4PIK3CDPI4KAPIK3CG
SCHEMBL29793825 0.81 CLK4 (0.49) CYP2A6IRAK4PIK3CDPI4KAPIK3CG
SCHEMBL5654040 0.81 PIM2 (0.45) CYP2A6IRAK4BACE1PIK3CDPIK3CA
SCHEMBL5155418 0.81 CTSL (0.49) CTSLCTSKCYP2A6HTR1AHTR7
SCHEMBL5888632 0.81 PIM2 (0.45) CYP2A6IRAK4BACE1PIK3CDPIK3CA
SCHEMBL13799171 0.79 CTSL (0.44) CTSLCTSKCYP2A6HTR1AHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108929263-B Arylamide Kv2.1 inhibitor and preparation method, pharmaceutical composition and application thereof 中国医学科学院药物研究所 2022-07-22 CN disclosed
CN-111108092-A Arylamide Kv2.1 inhibitor and preparation method, pharmaceutical composition and application thereof 中国医学科学院药物研究所 2020-05-05 CN disclosed
EP-1581516-A4 3-HETEROCYCLIC BENZYLAMIDE DERIVATIVES AS POTASSIUM CHANNEL OPENERS BRISTOL MYERS SQUIBB CO (US) 2007-10-17 EP disclosed
EP-1581516-A2 3-HETEROCYCLIC BENZYLAMIDE DERIVATIVES AS POTASSIUM CHANNEL OPENERS Bristol-Myers Squibb Company (US) 2005-10-05 EP disclosed
WO-2004047744-A2 3-HETEROCYCLIC BENZYLAMIDE DERIVATIVES AS POTASSIUM CHANNEL OPENERS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-06-10 WO disclosed